Illumina ILMN announced that Magistrate Judge Elizabeth
D. Laporte of the U.S. District Court for the Northern District of
California granted Illumina's request to file a motion seeking
reconsideration of the Court's October 16, 2012 ruling invalidating
certain claims of U.S. Patent No. 6,306,597, which is being asserted by
Illumina against Complete Genomics, Inc. Under Judge Laporte's order,
Illumina is permitted to file briefing asking the Court to reconsider
its earlier ruling invalidating claims 14 and 15 of the ‘597 patent.
Illumina will seek a January 8, 2013 hearing date on the motion for
reconsideration.
Jay Flatley, Illumina's President and CEO, stated, “We are very pleased
that the Court has agreed to review
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in